Breaking the Exercise Paradox: New Hope from Leigh Syndrome Research
A Conversational Look at Groundbreaking Research
When Dr. Sundeep Dugar addressed the Global Meeting for Leigh Syndrome remotely this year, he brought with him 16 years of mitochondrial research and a message that could change how we think about treating this devastating disease. His presentation walked through complex science with remarkable clarity, building to a conclusion that offers genuine hope: what if we could give Leigh syndrome patients the benefits of exercise without requiring them to exercise?
The Mitochondrial Magic Trick
Dr. Dugar started his presentation with something that sounds almost impossible. Mitochondria, he explained, are the only component in your cells that can make more of themselves when needed, fix themselves when broken, and get rid of themselves when not needed. It’s cellular self-management at its finest, all governed by a process called hormesis.
He showed how mitochondria create ATP through what amounts to a chemical magic trick. They force two negatively charged molecules together, like pushing the south poles of two magnets until they connect. “Think about it,” he said. “When you have a south pole of a magnet combining with another south pole of another magnet, there’s inherent repulsion. But mitochondria are able to do it.” The result? They store massive amounts of energy in ATP, the molecule that powers literally everything you do.
The numbers are staggering. We have about 100,000 trillion mitochondria in our bodies. A healthy person produces their body weight in ATP every single day. That’s 150 to 160 pounds of energy currency, created fresh daily through chemistry that scientists can’t replicate in a laboratory.
When the System Breaks Down
Then Dr. Dugar turned to Leigh syndrome itself, walking his audience through exactly what goes wrong. The presentation showed how mutations in either nuclear DNA or mitochondrial DNA disrupt the electron transport chain, those protein complexes (labeled I through V in his slides) that create the proton gradient necessary for ATP production.
What makes Leigh syndrome so complex, he explained, is something called heteroplasmy. Unlike typical genetic inheritance where daughter cells match their parents, mitochondrial mutations distribute unevenly. A cell with 40% damaged mitochondria might divide to create one daughter cell with only 20% damage and another with 60%. When that 60% cell divides again, it might produce a cell with 80% dysfunctional mitochondria.
This unequal distribution, shown clearly in his presentation slides, explains why Leigh syndrome affects every patient differently and why symptoms can vary dramatically between tissues in the same individual. The degree of heteroplasmy literally determines the severity of disease.
The Cruel Catch-22
Here’s where Dr. Dugar’s presentation revealed the central problem. The accumulation of damaged mitochondria leads to something he called “a competition between cells making more mitochondria and cells losing excessive mitochondria.” When damaged mitochondria pile up, they depolarize, generate harmful reactive oxygen species, and produce inadequate ATP.
But clearing out these damaged mitochondria through mitophagy requires energy. ATP. The very thing these damaged mitochondria can’t produce enough of. “The cells don’t have enough energy to invest in getting rid of these dysfunctional mitochondria,” Dr. Dugar explained, “so they accumulate.”
It’s a vicious cycle. You need energy to clear damaged energy producers. When you don’t have energy, the damaged ones keep piling up.
The Exercise Solution No One Can Use
Dr. Dugar then walked through current treatment approaches being explored: mitochondrial replacement therapy, gene therapy, various supplements, dietary interventions. But he kept returning to one fundamental truth: “Exercise is the most natural way we know of improving mitochondrial function, protecting mitochondria from damage, and inducing new mitochondria through biogenesis.”
Then came the moment his presentation had been building toward. “However,” he said, letting the word hang in the air, “the common symptom of Leigh syndrome is exercise intolerance or inability to exercise.”
The audience could see the paradox clearly. Exercise would help these patients. But they can’t exercise. It’s like telling someone dying of thirst that water is at the bottom of a well they’re too weak to climb out of.
The Breakthrough Discovery
This is where years of research paid off. Dr. Dugar’s team asked a question nobody had answered: What happens biochemically when you exercise that creates new mitochondria? His presentation revealed their discovery of a novel steroid hormone that mitochondria produce during exercise, a hormone that initiates all the beneficial outcomes we associate with physical activity.
Even more remarkably, they found that epicatechin (a natural compound found in tea and cacao) structurally mimics this exercise-induced steroid. The slides showed how epicatechin enhances mitochondrial activity, increases biogenesis, boosts the density of cristae (where ATP is made), and protects mitochondria from damage.
From Science to Hope
Dr. Dugar’s conclusion was measured but meaningful. If epicatechin can provide Leigh syndrome patients the benefits of exercise even when they have exercise intolerance, it could improve mitochondrial function and levels, induce the mitophagy needed to clear damaged mitochondria, reduce oxidative stress, and improve endurance while reducing fatigue.
“The idea would be improving endurance, reducing fatigue, potentially slowing progression, improving aerobic capacity, and improving quality of life,” he summarized. “All through the basis of improved mitochondrial function.”
This isn’t about curing the genetic mutations underlying Leigh syndrome. Those remain. But by supporting the cells’ natural capacity for mitochondrial renewal and quality control, there may be a pathway toward better management and improved quality of life.
For families dealing with Leigh syndrome, Dr. Dugar’s presentation offered something precious: scientifically grounded hope. The exercise paradox may finally have a solution.
See the full presentation here:
About the Research: Dr. Sundeep Dugar is a pharmaceutical researcher, co-inventor of Zetia, and founder of Blue Oak Nutraceuticals. His research on exercise-induced steroids and epicatechin has been documented in both preclinical and clinical studies.
Medical Disclaimer: This article discusses research presented at a scientific conference. It does not constitute medical advice. Always consult qualified healthcare professionals regarding treatment decisions for Leigh syndrome or any medical condition. The research discussed involves ongoing studies and is not FDA-approved treatment.
Learn More: Blue Oak Nutraceuticals: www.blueoaknx.com